N-methyl D-aspartate induced mechanical allodynia is blocked by nitric oxide synthase and cyclooxygenase-2 inhibitors

NeuroReport

Volumn 10, Issue 3, 1999, Pages 449-452

  Dolan, Sharron ^a   Nolan, Andrea M ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Allodynia; Cyclooxygenase 2; Mechanical; Nitric oxide; NMDA; Spinal cord

Indexed keywords

3 (3 FLUOROPHENYL) 5,5 DIMETHYL 4 (4 METHYLSULFONYLPHENYL) 2(5H) FURANONE; 6,7 DINITRO 2,3 QUINOXALINEDIONE; ALPHA METHYL 4 CARBOXYPHENYLGLYCINE; CYCLOOXYGENASE 2 INHIBITOR; DIZOCILPINE; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; N(G) NITROARGININE; NITRIC OXIDE SYNTHASE INHIBITOR;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; SHEEP; SPINAL CORD; WITHDRAWAL REFLEX;

EID: 0033601984     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902250-00002     Document Type: Article

References (26)

1. 1. Coderre TJ and Melzack R. J. Neurosci 12, 3665-3670 (1992).
2. 2. Ren K, Williams GM, Hylden JLK, Ruda MA et al. Eur J Pharmacol 219, 235-243 (1992).
3. 3. Mao J, Price DD, Hayes RL. Lu J et al. Brain Res 598, 271-278 (1992).
4. 4. Malmberg AB and Yaksh TL. Science 287, 1276-1279 (1992).
5. 5. Meller ST, Dykstra C and Gebhart GF. Neuroscience 71, 327-335 (1996).
6. 6. Meller ST, Dykstra CL and Gebhart GF. NeuroReport, 879-882 (1993).
7. 7. Laird JMA, Mason GS, Webb J, Hill RG et al. Br J Pharmacol 117, 1487-1492 (1996).
8. 8. Ren K and Dubner R. Neurosci Lett 163, 22-26 (1993).
9. 9. Yaksh TL. Pain 37, 111-123 (1989).
10. 10. Kim YI, Na HS, Yoon YW, Han HC et al. NeuroReport 6, 2149-2153 (1997).
11. 11. Meller ST. Cummings CP, Traub RJ and Gebhart GF. Neuroscience 60, 367-374 (1994).
12. 12. Hay CH, Trevethick MA, Wheeldon A et al. Neuroscience 78, 843-850 (1997).
13. 13. Lam HHD, Hanley DF, Trapp BD et al. Neurosci Lett 210, 201-204 (1996).
14. 14. Salvemini D, Misto TP, Masferrer JL et al. Proc Natl Acad Sci USA 90, 7240-7244 (1993).
15. 15. Tetsuka I, Daphnaiken D, Srivastava SK et al. Proc Natl Acad Sci USA 91, 12168-12172 (1994).
16. 16. Kyles AE, Waterman A and Livingston A. J Pharm Toxicol Methods 27, 177-183 (1992).
17. 17. Nolan A. Livingston A, Morris R and Waterman A. J Pharmacol Methods 17, 39-49 (1987).
18. 18. Riendeau O. Percival MD, Boyce S et al. Br J Pnarmacol 121, 105-117 (1997).
19. 19. Tverskoy M, Oz Y, Isakson A et al. Anesth Analg 78, 205-209 (1994).
20. 20. Minami T, Nishihara I, Ito S et al. Pain 61, 286-290 (1995).
21. 21. Minami T, Uda R, Horiguchi S et al. Pain 57, 217-223 (1994).
22. 22. Handy RLC and Moore PK. Neuropharmacology 37, 37-43 (1998).
23. 23. Kitto KF, Haley JE and Wilcox GL. Neurosci Lett 148, 1-5 (1992).
24. 24 Yamamoto T and NozakiTaguchi N. NeuroReport 8, 2179-2182 (1987).
25. 25. Yoon YW, Sung B and Chung JW. NeuroReport 9, 367-372 (1998).
26. 26. Haley JE and Wilcox GL. Hyperalgesia and Allodynia, New York: Raven Press, 1992: 281.